Thesis Anh Thu Pham Updated
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
World Journal of Pharmaceutical Research Vangalapati Et Al
World Journal of Pharmaceutical ReseaRch Vangalapati et al. World Journal of Pharmaceutical SJIF Research Impact Factor 5.045 Volume 3, Issue 6, 2127-2139. Review Article ISSN 2277 – 7105 A REVIEW ON CHEBULINIC ACID FROM MEDICINAL HERBS Surya Prakash DV1 and Meena Vangalapati2* 1 Research scholar, Centre for Biotechnology, Department of Chemical Engineering, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India. 2* Associate Professor, Centre for Biotechnology, Department of Chemical Engineering, Andhra University, Visakhapatnam-530003, Andhra Pradesh, India. Article Received on ABSTRACT 30 June 2014, Chebulinic acid is a phenolic compound found in the fruits of Revised on 25 July 2014, Accepted on 20 August 2014 Terminalia chebula (Haritaki), Phyllanthus emblica (Amla) and seeds of Dimocarpus longan (Longan) species etc. It’s also known as 1,3,6- *Correspondence for Tri-O-galloyl-2,4-chebuloyl-β-D-glucopyranoside. Chebulinic acid is Author extracted from the medicinal herbs using soxhlet extractor, column Dr. Meena Vangalapati chromatography and high pressure liquid chromatography (HPLC) etc. Associate Professor, Centre for It showed many pharmacological activities including inhibition of Biotechnology, Department of cancer cell growth like human leukemia K562 cells, colon Chemical Engineering, Andhra University, adenocarcinoma HT-29 cell lines, anti-neisseria gonorrhoeae activity, Visakhapatnam-530003, inhibiting the contractile responses of cardiovascular muscles activities Andhra Pradesh, India. etc. KEY WORDS: Chebulinic acid, Terminalia chebula, Dimocarpus longan, Phyllanthus emblica, Anticancer activity, HPLC, Astringency. INTRODUCTION Chebulinic acid is a phenolic compound [1,2] commonly found in the fruits of Terminalia chebula, leaves and fruits of Phyllanthus emblica and seeds of Dimocarpus longan species, which has many potential uses in medicine. -
Molecular Docking Studies of Medicinal Compounds Against Aldose Reductase Drug Target for Treatment of Type 2 Diabetes Pratistha Singh*1, Preeti Yadav2, V.K
Intl. J. Bioinformatics and Biological Sci.: (V. 5 n.2, p. 91-116): December 2017 ©2017 New Delhi Publishers. All rights reserved DOI: 10.5958/2321-7111.2017.00012.9 Molecular Docking Studies of Medicinal Compounds against Aldose reductase Drug Target for Treatment of Type 2 Diabetes Pratistha Singh*1, Preeti Yadav2, V.K. Singh3 and A.K. Singh1 1Department of Dravyaguna, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India 2School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi, India 3Centre for Bioinformatics, School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi, India *Corresponding author: [email protected] ABSTRACT Type 2 Diabetes is a disease that manifests from combined effect of genetic and environmental stress on multiple tissues over a period of time. An enzyme, Aldose Reductase play an important role in oxidative stress and Diabetic Mellitus was selected as a target protein for in silico screening of suitable herbal inhibitors using molecular docking. In the present work best screened ligands Ajoene, 3-O-methyl-D-chiro-inositol (D-pinitol), Butein, Leucopelargonidin, Nimbidinin, Tolbutamide and Coumarin were used for docking calculation and isolated from Allium sativum, Glycine max, Butea monosperma, Thepsia populena, Ficus benghalensis, Azardirachta indica, Nelumbo nucifera, Aegle marmelos respectively. Herbacetin and Quercetin from Thepsia populena. The residues Gly18, Thr19, Trp20, Lys21, Asp43,Val47, Tyr48, Gln49, Asn50, Lys77, His110, Trp111, Thr113, Ser159, Asn160, Asn162, His163, Gln183, Tyr209, Ser210, Pro211, Leu212, Gly213, Ser214, Pro215, Asp216, Ala245, Ile260, Val264, Thr265, Arg268, Glu261, Asn262, Cys298, Ala299 and Leu300 were found conserved with binding site 1, which is major active site involved in interaction. -
In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: a Case of Padma Hepatenr Formulation
Article In Vitro Bioaccessibility, Human Gut Microbiota Metabolites and Hepatoprotective Potential of Chebulic Ellagitannins: A Case of Padma Hepatenr Formulation Daniil N. Olennikov 1,*, Nina I. Kashchenko 1,: and Nadezhda K. Chirikova 2,: Received: 28 August 2015 ; Accepted: 30 September 2015 ; Published: 13 October 2015 1 Laboratory of Medical and Biological Research, Institute of General and Experimental Biology, Siberian Division, Russian Academy of Science, Sakh’yanovoy Street 6, Ulan-Ude 670-047, Russia; [email protected] 2 Department of Biochemistry and Biotechnology, North-Eastern Federal University, 58 Belinsky Street, Yakutsk 677-027, Russian; [email protected] * Correspondence: [email protected]; Tel.: +7-9021-600-627; Fax: +7-3012-434-243 : These authors contributed equally to this work. Abstract: Chebulic ellagitannins (ChET) are plant-derived polyphenols containing chebulic acid subunits, possessing a wide spectrum of biological activities that might contribute to health benefits in humans. The herbal formulation Padma Hepaten containing ChETs as the main phenolics, is used as a hepatoprotective remedy. In the present study, an in vitro dynamic model simulating gastrointestinal digestion, including dialysability, was applied to estimate the bioaccessibility of the main phenolics of Padma Hepaten. Results indicated that phenolic release was mainly achieved during the gastric phase (recovery 59.38%–97.04%), with a slight further release during intestinal digestion. Dialysis experiments showed that dialysable phenolics were 64.11% and 22.93%–26.05% of their native concentrations, respectively, for gallic acid/simple gallate esters and ellagitanins/ellagic acid, in contrast to 20.67% and 28.37%–55.35% for the same groups in the non-dialyzed part of the intestinal media. -
Plants of Cat Tien National Park DANH LỤC THỰC VẬT VƯỜN
Plants of Cat Tien National Park 22 January 2017 * DANH LỤC THỰC VẬT VƯỜN QUỐC GIA CÁT TIÊN Higher Family Chi - Loài NGÀNH / LỚP v.v. HỌ / HỌ PHỤ Rec. No. Clas. (& sub~) Species Authority ssp., var., syn. etc. & notes TÊN VIỆT NAM Ds Cd Mã số Clade: Embryophyta Nhánh: Thực vật có phôi (Division) Marchantiophyta Liverworts Ngành Rêu tản (Division) Anthocerotophyta Hornworts Ngành Rêu sừng (Division) Bryophyta Mosses Ngành Rêu Tracheophyta: Vascular plants: Thực vật có mạch: (Division) Lycopodiophyta clubmosses, etc Ngành Thạch tùng Lycopodiaceae 1. HỌ THẠCH TÙNG Huperzia carinata (Poir.) Trevis Thạch tùng sóng K C - T 4 Huperzia squarrosa (Forst.) Trevis Thạch tùng vảy K T 12 Huperzia obvalifolia (Bon.) Thạch tùng xoan ngược K C - T 8 Huperzia phlegmaria (L.) Roth Râu cây K C - T 9 Lycopodiella cernua (L.) Franco & Vasc Thạch tùng nghiên K T 16 Lycopodiella sp. Thạch tùng K T Selaginellaceae spikemosses 2. HỌ QUYỂN BÁ Selaginella delicatula (Desv) Alst. Quyển bá yếu K T 41 Selaginella rolandi-principis Alston. Hoa đá K T 27 Selaginella willdenowii (Desv.) Baker. Quyển bá Willdenov K T 33 Selaginella chrysorrhizos Spring Quyển bá vàng K 39 Selaginella minutifolia Spring Quyển bá vi diệp K 49 (Division) Pteridophyta (Polypodiophyta) Leptosporangiate ferns Ngành Dương xỉ Class: Marattiopsida Lớp Dương xỉ tòa sen Marattiaceae (prev. Angiopteridaceae) 4. HỌ HIỀN DỰC Angiopteris repandulade Vriese. Ráng hiền dực K 82 Class: Pteridopsida or Polypodiopsida Lớp Dương xỉ Order: Polypodiales polypod ferns Bộ Dương xỉ Aspleniaceae 5. HỌ CAN XỈ Asplenium nidus L. Ráng ổ phụng K 456 Asplenium wightii Eatoni Hook. -
(12) Patent Application Publication (10) Pub. No.: US 2006/0165636A1 Hasebe Et Al
US 2006O165636A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0165636A1 HaSebe et al. (43) Pub. Date: Jul. 27, 2006 (54) HAIR TREATMENT COMPOSITION AND (52) U.S. Cl. .......................................................... 424/70.14 HAIR COSMETC FOR DAMAGED HAIR (76) Inventors: Kouhei Hasebe, Gifu (JP); Kikumi (57) ABSTRACT Yamada, Gifu (JP) Correspondence Address: The present invention intends to provide a composition for FRISHAUF, HOLTZ, GOODMAN & CHICK, PC hair treatment containing Y-polyglutamic acid or a salt 220 Fifth Avenue thereof, a hair cosmetic for damaged hair containing Such a 16TH Floor composition, and their uses. The composition for hair treat NEW YORK, NY 10001-7708 (US) ment containing Y-polyglutamic acid or a salt thereof and the hair cosmetic for damaged hair of the present invention have (21) Appl. No.: 10/547,492 excellent improvement effects on the strength and frictional (22) PCT Filed: Mar. 3, 2004 force of hair, so that they can provide tension, elasticity, or the like to damage hair to prevent or alleviate split hair and (86). PCT No.: PCT/PO4/O2606 broken hair as well as improvements in combing and touch. (30) Foreign Application Priority Data Furthermore, they also exert effects of moisture retention inherent to Y-polyglutamic acid or a salt thereof, preventing Mar. 10, 2003 (JP)......................................... 2003-62688 or improving effects on the generation of dandruff on the basis of such effects, preventing effects on the feeling of Publication Classification Stickiness or creak, and various effectiveness including (51) Int. Cl. appropriate residual tendency to hair in a simultaneous A6 IK 8/64 (2006.01) manner, respectively. -
Terminalia Chebula: Success from Botany to Allopathic and Ayurvedic Pharmacy
Online - 2455-3891 Vol 9, Issue 5, 2016 Print - 0974-2441 Review Article TERMINALIA CHEBULA: SUCCESS FROM BOTANY TO ALLOPATHIC AND AYURVEDIC PHARMACY VARUN GARG, BARINDER KAUR, SACHIN KUMAR SINGH*, BIMLESH KUMAR Department of Pharmacy, School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India. Email: [email protected]/[email protected] Received: 25 May 2016, Revised and Accepted: 27 May 2016 ABSTRACT Terminalia chebula (TC) is a unique herb having various therapeutic potentials as anti-inflammatory, antioxidant, anticancer, and digestant. It belongs to family Combretaceae. In the present review, an attempt has been made to decipher classification, chemical constituents, therapeutic uses, and patents that have been reported for TC. Various pharmacological activities of TC that make it as potential medicine and its Ayurvedic formulations are highlighted. Keywords: Terminalia chebula, Anti-oxidant, Anti-cancer, Ayurvedic formulations, Anti-oxidant. © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2016.v9i5.13074 INTRODUCTION above variety. These are alterative, stomachic, laxative, and tonic. It is generally used in fevers, cough, asthma, urinary diseases, piles, worms (TC) is a unique herb that is used from ancient Terminalia chebula and rheumatism and scorpion-sting. time since Charak. It is used in many herbal formulations like Triphala. It is used as anti-inflammatory and digestant [1-3]. In recent years, an extract of TC has been reported for having anticancer and Balaharade antioxidant properties [1-3]. TC belongs to Kingdom: Plantae, Division: This variety is smaller than above two mentioned categories, its color Magnoliophyta, Class: Magnoliopsida, Order: Myrtales, Family: is homogenous, and the pulp is deep brown. -
Obdiplostemony: the Occurrence of a Transitional Stage Linking Robust Flower Configurations
Annals of Botany 117: 709–724, 2016 doi:10.1093/aob/mcw017, available online at www.aob.oxfordjournals.org VIEWPOINT: PART OF A SPECIAL ISSUE ON DEVELOPMENTAL ROBUSTNESS AND SPECIES DIVERSITY Obdiplostemony: the occurrence of a transitional stage linking robust flower configurations Louis Ronse De Craene1* and Kester Bull-Herenu~ 2,3,4 1Royal Botanic Garden Edinburgh, Edinburgh, UK, 2Departamento de Ecologıa, Pontificia Universidad Catolica de Chile, 3 4 Santiago, Chile, Escuela de Pedagogıa en Biologıa y Ciencias, Universidad Central de Chile and Fundacion Flores, Ministro Downloaded from https://academic.oup.com/aob/article/117/5/709/1742492 by guest on 24 December 2020 Carvajal 30, Santiago, Chile * For correspondence. E-mail [email protected] Received: 17 July 2015 Returned for revision: 1 September 2015 Accepted: 23 December 2015 Published electronically: 24 March 2016 Background and Aims Obdiplostemony has long been a controversial condition as it diverges from diploste- mony found among most core eudicot orders by the more external insertion of the alternisepalous stamens. In this paper we review the definition and occurrence of obdiplostemony, and analyse how the condition has impacted on floral diversification and species evolution. Key Results Obdiplostemony represents an amalgamation of at least five different floral developmental pathways, all of them leading to the external positioning of the alternisepalous stamen whorl within a two-whorled androe- cium. In secondary obdiplostemony the antesepalous stamens arise before the alternisepalous stamens. The position of alternisepalous stamens at maturity is more external due to subtle shifts of stamens linked to a weakening of the alternisepalous sector including stamen and petal (type I), alternisepalous stamens arising de facto externally of antesepalous stamens (type II) or alternisepalous stamens shifting outside due to the sterilization of antesepalous sta- mens (type III: Sapotaceae). -
Screening of the Antioxidant Potential of Young and Mature Leaves of Saraca Indica and Ficus Religiosa a Comparative Study
International Journal of Int. J. of Life Sciences, 2019; 7 (4):753-759 Life Sciences ISSN:2320-7817(p) | 2320-964X(o) International Peer Reviewed Open Access Refereed Journal Original Article Open Access Screening of the antioxidant potential of young and mature leaves of Saraca indica and Ficus religiosa a comparative study Khetade Roshan H1*, Bharsagade Prachi D2, Patil Pranali2 and Umekar Milind J3 Department of Quality Assurance, Smt. Kishoritai Bhoyar College of Pharmacy, Behind Railway Station, Kamptee Dist. Nagpur-441002. *Address for Corresponding Author : Mr. Roshan H. Khetade Email- [email protected] | Contact No.9595050017 Manuscript details: ABSTRACT Received: 01.07.2019 Saraca indica, commonly known as Asoka-tree, ashok or simply Asoca is a Accepted: 10.12.2019 plant belonging to the subfamily Detarioideae of the family Fabaceae. In Published: 30.12.2019 Ayurveda, the bark is used in indigestion, pyrexia, burning sensation, colic, ulcers, menorrhagia, vaginal discharge and acnes and Ficus religiosa or sacred fig is a species of fig native to the Indian subcontinent Cite this article as: and Indochina that belongs to Moraceae, the comparative study for total Khetade Roshan H, Bharsagade tannin content by folin-denis reagent for Saraca indica for the methanolic Prachi D, Patil Pranali and Umekar extract of young leaves of Saraca indica contains more percentage of Milind J (2019) Screening of the tannic acid as compared to mature leaves and young leaves of Ficus antioxidant potential of young and religiosa contains more percentage of tannic acid as compared to mature mature leaves of Saraca indica and leaves. Total flavonoid content for Saraca indica for the methanolic Ficus religiosa a comparative study, extract of young leaves of Saraca indica contains more percentage of Int. -
Combretaceae: Phylogeny, Biogeography and DNA
COPYRIGHT AND CITATION CONSIDERATIONS FOR THIS THESIS/ DISSERTATION o Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. o NonCommercial — You may not use the material for commercial purposes. o ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. How to cite this thesis Surname, Initial(s). (2012) Title of the thesis or dissertation. PhD. (Chemistry)/ M.Sc. (Physics)/ M.A. (Philosophy)/M.Com. (Finance) etc. [Unpublished]: University of Johannesburg. Retrieved from: https://ujdigispace.uj.ac.za (Accessed: Date). Combretaceae: Phylogeny, Biogeography and DNA Barcoding by JEPHRIS GERE THESIS Submitted in fulfilment of the requirements for the degree PHILOSOPHIAE DOCTOR in BOTANY in the Faculty of Science at the University of Johannesburg December 2013 Supervisor: Prof Michelle van der Bank Co-supervisor: Dr Olivier Maurin Declaration I declare that this thesis has been composed by me and the work contained within, unless otherwise stated, is my own. _____________________ J. Gere (December 2013) Table of contents Table of contents i Abstract v Foreword vii Index to figures ix Index to tables xv Acknowledgements xviii List of abbreviations xxi Chapter 1: General introduction and objectives 1.1 General introduction 1 1.2 Vegetative morphology 2 1.2.1 Leaf morphology and anatomy 2 1.2.2. Inflorescence 3 1.2.3 Fruit morphology 4 1.3 DNA barcoding 5 1.4 Cytology 6 1.5 Fossil record 7 1.6 Distribution and habitat 7 1.7 Economic Importance 8 1.8 Taxonomic history 9 1.9 Aims and objectives of the study 11 i Table of contents Chapter 2: Molecular phylogeny of Combretaceae with implications for infrageneric classification within subtribe Terminaliinae. -
Threats to Australia's Grazing Industries by Garden
final report Project Code: NBP.357 Prepared by: Jenny Barker, Rod Randall,Tony Grice Co-operative Research Centre for Australian Weed Management Date published: May 2006 ISBN: 1 74036 781 2 PUBLISHED BY Meat and Livestock Australia Limited Locked Bag 991 NORTH SYDNEY NSW 2059 Weeds of the future? Threats to Australia’s grazing industries by garden plants Meat & Livestock Australia acknowledges the matching funds provided by the Australian Government to support the research and development detailed in this publication. This publication is published by Meat & Livestock Australia Limited ABN 39 081 678 364 (MLA). Care is taken to ensure the accuracy of the information contained in this publication. However MLA cannot accept responsibility for the accuracy or completeness of the information or opinions contained in the publication. You should make your own enquiries before making decisions concerning your interests. Reproduction in whole or in part of this publication is prohibited without prior written consent of MLA. Weeds of the future? Threats to Australia’s grazing industries by garden plants Abstract This report identifies 281 introduced garden plants and 800 lower priority species that present a significant risk to Australia’s grazing industries should they naturalise. Of the 281 species: • Nearly all have been recorded overseas as agricultural or environmental weeds (or both); • More than one tenth (11%) have been recorded as noxious weeds overseas; • At least one third (33%) are toxic and may harm or even kill livestock; • Almost all have been commercially available in Australia in the last 20 years; • Over two thirds (70%) were still available from Australian nurseries in 2004; • Over two thirds (72%) are not currently recognised as weeds under either State or Commonwealth legislation. -
Distribution Models and a Dated Phylogeny for Chilean Oxalis Species Reveal Occupation of New Habitats by Different Lineages, Not Rapid Adaptive Radiation
Syst. Biol. 61(5):823–834, 2012 © The Author(s) 2012. Published by Oxford University Press, on behalf of the Society of Systematic Biologists. All rights reserved. For Permissions, please email: [email protected] DOI:10.1093/sysbio/sys034 Advance Access publication on February 22, 2012 Distribution Models and a Dated Phylogeny for Chilean Oxalis Species Reveal Occupation of New Habitats by Different Lineages, not Rapid Adaptive Radiation CHRISTOPH HEIBL AND SUSANNE S. RENNER∗ Systematic Botany and Mycology, University of Munich, Menzinger Straße 67, 80638 Munich, Germany; ∗Correspondence to be sent to: Institute of Systematic Botany and Mycology, Menzinger Straße 67, 80638 Munich, Germany; E-mail: [email protected]. Received 1 August 2011; reviews returned 18 October 2011; accepted 17 January 2012 Associate Editor: Thomas Buckley Downloaded from Abstract.—Among the World’s most challenging environments for plant life is the Atacama Desert, an arid zone extending over 1300 km and from sea level to 2000/3000 m altitude along the southwestern Andean foothills. Plants there and in the adjacent Mediterranean zone exhibit striking adaptations, and we here address the question whether in a species- rich clade such adaptations arose in parallel, at different times, or simultaneously. Answering this type of question has been a major concern of evolutionary biology over the past few years, with a growing consensus that lineages tend to be conservative in their vegetative traits and niche requirements. Combined nuclear and chloroplast DNA sequences for 112 species of Oxalidales (4900 aligned nucleotides) were used for a fossil-calibrated phylogeny that includes 43 of the 54 http://sysbio.oxfordjournals.org/ species of Chilean Oxalis, and species distribution models (SDMs) incorporating precipitation, temperature, and fog, and the phylogeny were used to reconstruct ancestral habitat preferences, relying on likelihood and Bayesian techniques. -
Plant Medicines for Clinical Trial
Plant Medicines for Clinical Trial Edited by James David Adams Printed Edition of the Special Issue Published in Medicines www.mdpi.com/journal/medicines Plant Medicines for Clinical Trial Plant Medicines for Clinical Trial Special Issue Editor James David Adams MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor James David Adams University of Southern California USA Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal Medicines (ISSN 2305-6320) from 2016 to 2018 (available at: http://www.mdpi.com/journal/medicines/ special issues/clinical trial) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-023-1 (Pbk) ISBN 978-3-03897-024-8 (PDF) Cover image courtesy of James David Adams. Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Contents About the Special Issue Editor ...................................... vii Preface to ”Plant Medicines for Clinical Trial” ............................